2 options
Legal Analysis of Whether Trading Stock Based on Secret Information Obtained from Medical Researchers Could Be Considered Insider Trading Prohibited by the Federal Securities Laws.
Connect to full text Available online
View online- Format:
- Book
- Government document
- Author/Creator:
- Library of Congress. Congressional Research Service.
- Language:
- English
- Subjects (All):
- Financial institutions.
- Fraud.
- Medicine--Research.
- Medicine.
- Physical Description:
- 1 online resource (7 pages, digital, PDF file)
- Place of Publication:
- [Place of publication not identified] : [publisher not identified], 2005.
- System Details:
- text file
- Summary:
- Reviews reported cases of doctors selling confidential and critical details of their drug research to Wall Street firms, and assesses whether such activities constitute insider trading in violation of Federal securities laws.
- Notes:
- Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC.
- CRS Report.
- Other Format:
- Microfiche version: Library of Congress. Congressional Research Service. Legal Analysis of Whether Trading Stock Based on Secret Information Obtained from Medical Researchers Could Be Considered Insider Trading Prohibited by the Federal Securities Laws
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.